News | Proton Therapy | August 15, 2023

This contract is the second order from CGN Medical Technology for IBA’s Proteus PLUS system 

This contract is the second order from CGN Medical Technology for IBA’s Proteus PLUS system

August 15, 2023 — IBA, a world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announced it has signed an equipment contract with its partner CGN Medical Technology (CGNMT) for IBA’s Proteus PLUS[1] proton therapy system, with one gantry treatment room to be installed at the West China International Cancer Treatment Center in Chengdu, Sichuan Province. 

CGNMT is the sole proton therapy system vendor for West China International Cancer Treatment Center in Chengdu. Following the strategic licensing agreement signed between IBA and CGNNT in 2020, IBA provides the key components of the Proteus PLUS system to CGNMT which will be installed at the hospital site. CGNMT will be responsible for the installation, commissioning, service and maintenance of the proton therapy equipment. 

Olivier Legrain, Chief Executive Officer of IBA, commented: "This project is the ninth Proteus PLUS system to be installed in China and the second order received from CGNMT since the beginning of our successful collaboration. We were happy to meet the management team of CGNMT in person for the first time since the pandemic and the signature of our agreement. We have been impressed with the progress that has been made so far by our partner and look forward to continuing our relationship with them to ensure the future success and expansion of proton therapy in the Chinese market." 

HU Dongming, Chairman of CGN Nuclear Technology Development Co., Ltd., added: "We were happy to welcome Mr. Legrain and his team to CGN in Shenzhen and celebrate the fantastic progress we have made in the delivery of this innovative technology to the Chinese market. We are pleased and honored to be working with the West China International Cancer Treatment Center which demonstrates the potential of our collaboration for the benefit of cancer patients in China. We look forward to strengthening our relationship with IBA as we continue with this project." 

For more information: www.iba-worldwide.com


Related Content

News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Artificial Intelligence

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...

Time February 29, 2024
arrow
News | Radiology Imaging

February 23, 2024 — The American Society of Radiologic Technologists (ASRT) launched its "Be Seen" campaign today to ...

Time February 23, 2024
arrow
News | Teleradiology

February 21, 2024 —Yellowcross Healthcare Commerce, a telemedicine practice management organization, launched a new ...

Time February 21, 2024
arrow
News | Artificial Intelligence

February 22, 2024 — Hartford HealthCare has announced the unveiling of its Center for AI Innovation in Healthcare ...

Time February 21, 2024
arrow
Videos | Information Technology

Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and ...

Time February 21, 2024
arrow
News | Artificial Intelligence

February 13, 2024 — deepc GmbH, a leading AI operating system for radiologists and enterprise clinical organizations, is ...

Time February 13, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | Artificial Intelligence

February 8, 2024 — Paige, a global leader in end-to-end digital pathology solutions and clinical Artificial Intelligence ...

Time February 08, 2024
arrow
News | Artificial Intelligence

February 8, 2024 — Siemens Healthineers, a global leader in medical technology and in researching and training ...

Time February 08, 2024
arrow
Subscribe Now